Loading provider…
Loading provider…
Ophthalmology Physician in San Diego, CA
NPI: 1154582575Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D., PH.D. Eric's Phone Numberphone_androidMobile
Get M.D., PH.D. Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2014 - 2026
MI State Medical License
2012 - 2016
MO State Medical License
2009 - 2012

American Board of Ophthalmology
Ophthalmology
Washington University/B-JH/SLCH Consortium
Residency • Ophthalmology
2009 - 2012
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital
Internship • Internal Medicine
2008 - 2009
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 899 | 1,809 |
| 2 | 92134Diagnostic imaging of retina | 888 | 2,026 |
| 3 | 67028Injection of drug into eye | 136 | 699 |
| 4 | J7999Compounded drug, not otherwise classified | 98 | 560 |
| 5 | 92083Measurement of field of vision during daylight conditions | 23 | 23 |
Authors: Robison Chan, John Campbell, Michael Chiang
Journal: JAMA Ophthalmol
PERIPHERAL RETINAL VASCULOPATHY IN COCKAYNE SYNDROME
Authors: Trese, Matthew G J, Nudleman, Eric D, Besirli, Cagri G
Journal: Retin Cases Brief Rep
Authors: Prethy Rao, Sarah Read, Nikisha Kothari, Antonio Capone, Philip Ferrone, Emmanuel Chang, Robert Sisk, Caroline Baumal, William Smiddy
Journal: J Vitreoretin Dis
Publication Date: 2019-11-18
Lead Sponsor: University of California, San Diego
Collaborators: California Institute for Regenerative Medicine (CIRM), Cystinosis Research Foundation
Intervention / Treatment: GENETIC: CTNS-RD-04 or CTNS-RD-04-LB (where the suffix "-LB" stands for LentiBOOST)
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Bayer
Intervention / Treatment: DRUG: Intravitreal Aflibercept Injection (IAI), DRUG: REGN910-3